Michael F. DeMane - 25 May 2021 Form 4 Insider Report for NEVRO CORP

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael DeMane
Issuer symbol
N/A
Transactions as of
25 May 2021
Net transactions value
$0
Form type
4
Filing time
26 May 2021, 21:03:33 UTC
Next filing
24 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +1,167 +0.49% $0.000000 237,722 25 May 2021 Direct F1, F2
holding NVRO Common Stock 38,054 25 May 2021 See footnote F3
holding NVRO Common Stock 21,800 25 May 2021 See footnote F4
holding NVRO Common Stock 30,218 25 May 2021 See footnote F5
holding NVRO Common Stock 2 25 May 2021 See footnote F6
holding NVRO Common Stock 47,980 25 May 2021 See footnote F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 25, 2021 or (ii) the next Annual Meeting following May 25, 2021, subject to the Reporting Person's continued service to the issuer.
F2 Includes 1,167 RSUs.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F4 Shares held by Michael DeMane Trustee, Michael F. DeMane 2016 Retained Annuity Trust U/A/D May 22, 2017.
F5 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2018 Retained Annuity Trust U/A 07/16/2018.
F6 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
F7 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 04/23/2021.